Dr. Ali has served as a board member of Amanat Holdings since November 2020, bringing more than twenty years of expertise in education and business development.
Dr. Musuva takes the helm following the departure of Dr. Tim Theuri, whose fixed-term contract as CEO concluded on February 8th, 2026.
Dr. Basson joins Variant Bio with more than 25 years of leadership experience spanning academic medicine, global pharmaceutical development, and biotechnology sectors.
The Board’s decision to extend Dr. Zoëga’s appointment reflects confidence in both his individual leadership and the broader executive team’s capabilities.
The newly appointed Secretary of State has established herself as a distinguished Senior Clinical Psychotherapist throughout her extensive career.
Dr. Kays, who previously served JOOTRH as an obstetrician-gynecologist, returns after completing two years of specialized training in maternal-fetal medicine.
The handover ceremony took place at the Kenya BioVax headquarters and was presided over by Dr. Charles Githinji, the Chairman of the Board of Directors.